EHC Q1 2026 Earnings Call Summary

Encompass Health (EHC) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

Revenue: Increased by 9% year-over-year to $1.59 billion.
Adjusted EBITDA: Rose 11.2% to $348.8 million.
Discharge Growth: Total discharge growth was 4.3%, with same-store discharge growth at 1.6%.
Net Revenue per Discharge: Increased by 3.7%, benefiting from patient mix and Medicare adjustments.
Bad Debt Expense: Increased by 20 basis points to 2.2%, primarily due to legacy audit appeals.
Annualized RN Turnover: Improved to 17.8%, down from 20.2% in FY 2025; therapist turnover decreased to 6.4%.
Adjusted Free Cash Flow: Reported at $194 million for Q1.
Share Repurchases: Approximately 708,000 shares repurchased for $71.6 million.

2. Strategic Updates and Business Highlights

Patient Outcomes: Improved discharge community rate to 84.5%, discharge acute rate to 8.6%, and discharge to SNF rate to 6.2%, all exceeding industry averages.
Capacity Expansion: Opened a new 49-bed hospital in Irma, SC, and added 44 beds to existing facilities. Plans to open 7 more hospitals with a total of 340 beds in 2026.
Small-Format Hospitals: Anticipating at least one small-format hospital opening in 2027 to complement existing strategies.
Regulatory Environment: Preparing for TEAM implementation and RCD expansion, with a proposed 2.4% pricing increase for Medicare patients expected in 2027.

3. Forward Guidance and Outlook

2026 Guidance Raised:
- Net operating revenue: $6.375 billion to $6.470 billion.
- Adjusted EBITDA: $1.35 billion to $1.38 billion.
- Adjusted earnings per share: $5.89 to $6.11.
CapEx Expectations: Anticipated to peak at about 15% of revenue over the next 2-3 years before stabilizing at 10-12%.

4. Bad News, Challenges, or Points of Concern

Impact of Unit Closures: Four IRF units closed, negatively affecting discharge growth by approximately 85 basis points, though this impact is expected to diminish over time.
Occupancy Constraints: Average occupancy at 78.7%, with some hospitals exceeding 90%, indicating potential limits on growth until new capacity is added.
Medicare Advantage (MA) Trends: Noted challenges with MA penetration, which has peaked and is now receding, potentially impacting future volumes.
Bad Debt Increase: Reflects ongoing challenges with claims from prior years, indicating potential financial risks.

5. Notable Q&A Insights

Same-Store Volume Performance: Adjusted for unit closures, same-store discharge growth remains healthy but moderated compared to previous trends.
Nursing Turnover: Lowest turnover since 2012 attributed to effective talent acquisition and career advancement programs.
Admit and Appeal Strategy: Early positive results from a pilot program aimed at improving approval rates for MA patients, with further rollout anticipated.
Small-Format Hospitals: Seen as a flexible solution to address capacity constraints in landlocked markets, with ongoing evaluations of potential sites.
Market Dynamics: Continued focus on capturing share from skilled nursing facilities (SNFs) as the demand for inpatient rehabilitation services grows, driven by an aging population.

Overall, EHC demonstrated strong financial performance in Q1 2026, with strategic initiatives focused on capacity expansion and improving patient outcomes, while navigating challenges related to regulatory changes and market dynamics.

EHC — Encompass Health Corporation